Arbutus Biopharma Corporation
SUBSTITUTED 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
Last updated:
Abstract:
The present disclosure includes substituted 2,2'-bipyrimidinyl compounds, analogues thereof, and compositions comprising the same, which can be used to treat and/or prevent hepatitis B virus (HBV) and/or hepatitis B virus (HBV)-hepatitis D virus (HDV) infection in a patient.
Status:
Application
Type:
Utility
Filling date:
14 May 2019
Issue date:
19 Aug 2021